Bristol-Myers Squibb Company (BMY) · page 12 of 16
The slide uses a bar chart to highlight BMY's high R&D investment relative to peers, framing it as a potential inefficiency or misallocation of capital.
Shareholder letter · peer_benchmark · compare_peers · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
chart 1/1 paragraph 3/3 source-note 1/1 title 1/1
Components 6
bar-vertical paragraph paragraph paragraph source-note action-title
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1